Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Winquist

Showing results (151-160 of 234) with videos related to

Pageof 24
Sort By:
Oral Oncology|August 13, 2021
Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancerAndrée Boucher, Shereen Ezzat, Sebastien Hotte, et al.
Oral Oncology|February 9, 2019
Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patientsWendy A Teft, Eric Winquist, Anthony C Nichols, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National SurveyEsmail M Al-Ezzi, Amer Zahralliyali, Aaron R Hansen, et al.
Head & Neck|March 25, 2009
Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinibLaura Vidal, Ming S Tsao, Gregory R Pond, et al.
JAMA Oncology|June 30, 2018
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Pathology Oncology Research : POR|August 15, 2015
Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell CarcinomaJulie A Theurer, William Stecho, John Yoo, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 7, 2019
Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinomaMark Warren, Michael Kolinsky, Christina M Canil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tractJoaquim Bellmunt, Christine Théodore, Tomasz Demkov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987Joaquim Bellmunt, Hans von der Maase, Graham M Mead, et al.
Nature Medicine|January 28, 2026
Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trialRicardo Fernandes, Behnam Jabbarizadeh, Adnan Rajeh, et al.
Pageof 24

Showing results (151-160 of 234) with videos related to

Sort By:
Pageof 24
Oral Oncology|August 13, 2021
Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancerAndrée Boucher, Shereen Ezzat, Sebastien Hotte, et al.
Oral Oncology|February 9, 2019
Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patientsWendy A Teft, Eric Winquist, Anthony C Nichols, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National SurveyEsmail M Al-Ezzi, Amer Zahralliyali, Aaron R Hansen, et al.
Head & Neck|March 25, 2009
Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinibLaura Vidal, Ming S Tsao, Gregory R Pond, et al.
JAMA Oncology|June 30, 2018
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Pathology Oncology Research : POR|August 15, 2015
Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell CarcinomaJulie A Theurer, William Stecho, John Yoo, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 7, 2019
Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinomaMark Warren, Michael Kolinsky, Christina M Canil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tractJoaquim Bellmunt, Christine Théodore, Tomasz Demkov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987Joaquim Bellmunt, Hans von der Maase, Graham M Mead, et al.
Nature Medicine|January 28, 2026
Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trialRicardo Fernandes, Behnam Jabbarizadeh, Adnan Rajeh, et al.
Pageof 24